Serum ferritin levels in West Nile encephalitis  by Cunha, B.A. et al.
with similar illness (fever, headache, vomiting,
etc.) are necessary. The present survey demon-
strates that dengue fever may be a problem in the
region of Attapeu Province. Further detailed
serological studies with inclusion of other ﬂavi-
viruses are recommended.
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ABSTRACT
West Nile encephalitis (WNE) presents clinically
as aseptic meningitis, meningoencephalitis,
encephalitis, or acute ﬂaccid paralysis. Non-spe-
ciﬁc laboratory ﬁndings, e.g., leukopenia and
thrombocytopenia, accompany WNE. Lymphope-
nia is marked and prolonged with WNE. Three
patients with WNE were found to have elevated
serum ferritin levels. Severity seemed to be
directly related to serum ferritin levels. Although
preliminary, the results suggested that serum
ferritin levels ‡ 500 ng ⁄mL (normal range 5–
187 ng ⁄mL) occur late with WNE, and not in a
control group of patients with viral meningitis or
encephalitis.
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West Nile encephalitis (WNE) ﬁrst appeared in
the USA in the New York area, and has subse-
quently spread westwards across the USA, with
cases in most states [1–4]. The clinical presenta-
tion may be manifested as aseptic meningitis,
meningoencephalitis, encephalitis, or acute motor
paralysis. The clinical course of WNE presents a
spectrum of illness ranging from mild aseptic
meningitis to fatal encephalitis. WNE is a diag-
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nostic possibility in patients with otherwise
aseptic meningitis or encephalitis, particularly
if accompanied by weakness and ⁄ or muscle
tremors. The possibility of WNE is further sug-
gested by the non-speciﬁc laboratory ﬁndings that
frequently accompany this arboviral infection,
e.g., leukopenia, lymphopenia and thrombocy-
topenia. Unlike other causes of viral meningitis or
encephalitis, the lymphopenia in WNE is marked
and prolonged [5]. Non-speciﬁc laboratory abnor-
malities have been described in cases of WNE.
This report describes three patients admitted to
Winthrop-University Hospital with a conﬁrmed
diagnosis of WNE in whom serum ferritin levels
were elevated late in the course of infection.
The three patients were conﬁrmed as suffering
from WNE on the basis of a positive WNE PCR
result and elevated IgM ELISA levels obtained by
the New York State Department of Health Labor-
atories. The patients presented with the typical
clinical ﬁndings of WNE, including encephalitis,
weakness and muscle tremors. The three patients
also had leukopenia, thrombocytopenia and pro-
longed lymphopenia. Serum transaminases were
mildly increased in two of the three patients.
Serum ferritin levels were highly elevated in all
three patients late (i.e., weeks 3–4) in the course of
WNE. Peak serum ferritin levels (normal range
5–187 ng ⁄mL) ranged between 594 ng ⁄mL and
3077 ng ⁄mL in the three patients: patient 1,
373–594 ng ⁄mL (mild WNE); patient 2, 1170–
1660 ng ⁄mL (moderate WNE); patient 3, 886–
3077 ng ⁄mL (fatal WNE). These elevated serum
ferritin levels peaked later and higher than might
be expected if ferritin was an acute-phase reac-
tant. None of the patients had disorders of iron
overload associated with high serum ferritin
levels, e.g., megaloblastic sideroblastic anaemias,
thalassaemia, hereditary spherocytosis, porphy-
ria, primary or metastatic carcinomas, lympho-
mas, leukaemias, haemosiderosis, chronic liver or
renal disease, hyperthyroidism, or Gaucher’s
disease. Serum ferritin levels in the WNE patients
remained elevated for days to weeks and gradu-
ally decreased with time (Fig. 1).
Ferritin is an iron storage protein complex of
iso-ferritins, produced by the reticuloendothelial
(RE) system. The RE system plays a critical role in
iron metabolism by processing the haemoglobin
from senescent red blood cells. In the absence of
disorders that affect iron metabolism, iron equi-
librium is regulated by macrophages of the RE
system which modulate iron release and iron
storage. There is an inverse relationship between
early release of iron from senescent red blood
cells and serum ferritin levels. Acutely, inﬂam-
mation and infection induce RE blockade of iron
release. This has the effect of decreasing serum
iron levels in inﬂammation, infection and neopl-
asia. The decrease in serum iron levels is part of
the febrile response to deny serum iron, a viru-
lence factor for many microorganisms, early in
infection. The mild and early increases in serum
ferritin during acute infection reﬂect the transfer
of serum iron into RE system storage to deprive
microorganisms of serum iron [6–11].
The late and sustained elevations in serum
ferritin levels observed in the three WNE patients
cannot be ascribed to the acute-phase response.
As an acute-phase reactant, ferritin may be
transiently or mildly elevated early in the course
of infection [6–8]. However, the elevated ferritin
levels seen in the WNE patients occurred late
(during the third to fourth weeks), and were
highly elevated beyond the levels attributable to
an acute-phase reactant of early infection. Six
control patients (age range 22–69 years) with viral
meningitis or encephalitis, who presented in the
same season, i.e., the summer, had normal
or near-normal serum ferritin levels, i.e., range
87–389 ng ⁄mL.
The reason why serum ferritin levels are ele-
vated in WNE is not clear. Serum ferritin levels
‡ 500 ng ⁄mL appear to be a late non-speciﬁc
laboratory feature of WNE. The magnitude of
Fig. 1. Late elevations of serum ferritin levels with mild
(patient 1), moderate (patient 2) and fatal (patient 3) West
Nile encephalitis. Days on the x-axis refer to hospital days.
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serum ferritin levels observed in the three patients
seemed to be related to the severity of WNE. The
results from these preliminary ﬁndings in three
patients need to be conﬁrmed in a larger cohort of
WNE patients.
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